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TX530 Optimal flow rate for antegrade cerebral perfusion
Takashi Sasaki, MD, Shoichi Tsuda, MD, R. Kirk Riemer, PhD, Chandra Ramamoorthy, MD,
V. Mohan Reddy, MD, and Frank L. Hanley, MD, Stanford, Calif
Cerebral blood flow was measured in neonatal piglets to determine its relation to pump flow during
ACP at 18C. We found that an ACP rate of 30 mL/kg/min provided a cerebral blood flow of
36 mL/100 g/min and oxygen delivery equal to standard cardiopulmonary bypass.
536 The Ross–Yacoub procedure for aneurysmal autograft roots: A strategy to
preserve autologous pulmonary valves
Giovanni Battista Luciani, MD, Francesca Viscardi, MD, Mara Pilati, MD, Antonia Maria Prioli, MD,
Giuseppe Faggian, MD, and Alessandro Mazzucco, MD, Verona, Italy
A strategy to salvage the autologous pulmonary valve is proposed in patients with autograft root
aneurysm, which entails remodeling with the Yacoub technique (Ross–Yacoub procedure). Referral
of patients before the onset of severe valve dysfunction is associated with successful outcome and
preservation of excellent quality of life.
543 Brain immaturity is associated with brain injury before and after neonatal
cardiac surgery with high-flow bypass and cerebral oxygenation monitoring
Dean B. Andropoulos, MD, MHCM, Jill V. Hunter, MD, David P. Nelson, MD, Stephen A. Stayer, MD,
Ann R. Stark, MD, E. Dean McKenzie, MD, Jeffrey S. Heinle, MD, Daniel E. Graves, PhD, and
Charles D. Fraser, Jr, MD, Houston, Tex
Using high-flow bypass technique including antegrade cerebral perfusion and near-infrared cerebral
oximetry, a 36% incidence of new brain injury was found on day 7 postoperative MRI in neonates
having cardiac surgery. Brain immaturity was associated with pre- and postoperative brain injury.
557 Larger aortic reconstruction corresponds to diminished left pulmonary artery
size in patients with single-ventricle physiology
Lakshmi P. Dasi, PhD, Kartik S. Sundareswaran, PhD, Colleen Sherwin, BS, Diane de Zelicourt, MS,
Kirk Kanter, MD, Mark A. Fogel, MD, and Ajit P. Yoganathan, PhD, Atlanta, Ga, and
Philadelphia, Pa
We studied the anatomic relationship between the aortic arch and left pulmonary artery (LPA) in 32
patients with single-ventricle physiology and showed that the LPA is physically limited in space
when the aorta is large from aortic reconstruction. This might be the underlying cause of the frequent
LPA stenosis seen in patients undergoing the Fontan operation.(continued on page 14A)
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TX562 Outcomes of the bidirectional Glenn procedure in patients less than
3 months of age
Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B. Manning, MD, and
Pirooz Eghtesady, MD, PhD, Campinas, Brazil, and Cincinnati, Ohio
The ideal age to perform the bidirectional Glenn (BDG) procedure remains uncertain. We compared
patients younger than 3 months with patients older than 3 months undergoing the BDG procedure.
The operative mortality and late results were similar in both groups. The BDG procedure is feasible
and safe in patients younger than 3 months.
569 Lesion-specific outcomes in neonates undergoing congenital heart surgery are
related predominantly to patient and management factors rather than
institution or surgeon experience: ACongenital Heart Surgeons Society Study
Tara Karamlou, MD, Brian W. McCrindle, MD, MPH, Eugene H. Blackstone, MD, Sally Cai, MSc,
Richard A. Jonas, MD, Scott M. Bradley, MD, David A. Ashburn, MD, MSc,
Christopher A. Caldarone, MD, and William G. Williams, MD, Toronto, Ontario, Canada,
Cleveland, Ohio, Washington, DC, Charleston, SC, and Ann Arbor, Mich
The role of institution and surgeon factors, including case volume, on the survival of 2421 neonates
with complex congenital heart disease was studied. Patient and management factors influenced
survival more than institution or surgeon experience. Institutional excellence in managing some
diagnostic groups does not indicate similar performance for all diagnostic groups.General Thoracic
Surgery (GTS)578 Evaluation of mediastinal lymph nodes with endobronchial ultrasound: The
thoracic surgeon’s perspective
Rafael S. Andrade, MD, Shawn S. Groth, MD, Natasha M. Rueth, MD, Jonathan D’Cunha, MD,
PhD, Stefan E. Pambuccian, MD, and Michael A. Maddaus, MD, FACS, Minneapolis, Minn
In the hands of experienced thoracic surgeons, excellent diagnostic results can be achieved with
EBUS-FNA of mediastinal lymph nodes. Thoracic surgeons are uniquely equipped to perform
necessary additional diagnostic and therapeutic procedures in the same setting as ultrasound-guided
fine-needle aspiration, thereby maximizing diagnostic yield and streamlining patient care.
584 Nonoperative thoracic duct embolization for traumatic thoracic duct leak:
Experience in 109 patients
Maxim Itkin, MD, John C. Kucharczuk, MD, Andrew Kwak, MD, Scott O. Trerotola, MD, and
Larry R. Kaiser, MD, Philadelphia, Pa, and Houston, Tex
Thoracic duct embolization is a minimally invasive alternative for thoracic duct ligation as a treatment
for chylous effusion.
591 Modulation of growth in human esophageal adenocarcinoma cells by group IIa
secretory phospholipase A2
David Mauchley, MD, Xianzhong Meng, MD, PhD, Thomas Johnson, PhD, David A. Fullerton, MD,
and Michael J. Weyant, MD, Aurora, Colo
Inhibition of secretory phospholipase A2 attenuates growth of human esophageal adenocarcinoma
cells. Secretory phospholipase A2 is a potential molecular target for the treatment of esophageal
adenocarcinoma.(continued on page 16A)
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TX600 Sutureless pneumostasis using bioabsorbable mesh and glue during major lung
resection for cancer: Who are the best candidates?
Kazuhiro Ueda, MD, Toshiki Tanaka, MD, Tao-Sheng Li, MD, Nobuyuki Tanaka, MD, and
Kimikazu Hamano, MD, Yamaguchi, Japan
We showed that the combination of bioabsorbable mesh and sealant was better than sealant alone for
reducing the duration of chest tube drainage, postoperative stay, and the incidence of postoperative
complications. It also identified which patients would benefit most from the combination of mesh and
sealant to achieve pneumostasis.
606 Bilobectomy for non–small cell lung cancer: A search for clinical factors that
may affect perioperative morbidity and long-term survival
Anthony W. Kim, MD, L. Penfield Faber, MD, William H. Warren, MD, Neha D. Shah, MD,
Sanjib Basu, PhD, and Michael J. Liptay, MD, Chicago, Ill
Bilobectomy can be performed with acceptable morbidity and mortality. As would be expected, long-
term survival relates to disease stage. Optimal survival benefit occurs when the indication for
bilobectomy is squamous cell carcinoma extending across the fissure. Age and type of bilobectomy
can also influence survival.
612 Determination of the minimum number of lymph nodes to examine to maximize
survival in patients with esophageal carcinoma: Data from the Surveillance
Epidemiology and End Results database
Shawn S. Groth, MD, Beth A. Virnig, PhD, Bryan A. Whitson, MD, Todd E. DeFor, MS,
Zhong-ze Li, MS, Todd M. Tuttle, MD, and Michael A. Maddaus, MD, Minneapolis, Minn
We used a US population–based cancer registry to determine the minimum number of lymph nodes
that should be evaluated pathologically in patients undergoing esophagectomy for esophageal
carcinoma. At least 30 lymph nodes should be evaluated to maximize overall and cancer-specific
survival.Acquired Cardiovascular
Disease (ACD)621 Preoperative very short-term, high-dose erythropoietin administration
diminishes blood transfusion rate in off-pump coronary artery bypass:
A randomized blind controlled study
Luca Weltert, MD, Stefano D’Alessandro, MD, Saverio Nardella, MD, Fabiana Girola, MD,
Alessandro Bellisario, MD, Daniele Maselli, MD, and Ruggero De Paulis, MD, Rome, Italy
We randomized 320 consecutive patients presenting for off-pump isolated revascularization to very
short-term (2 days before surgery and 3 days after surgery), high-dose erythropoietin (600 UI/kg/
wk) or a control group. Patients in the erythropoietin group showed significantly higher hemoglobin
values and a significantly lower need for allogenic blood transfusion.
628 Is robotic mitral valve repair a reproducible approach?
Wen Cheng, MD, Gregory P. Fontana, MD, Michele A. De Robertis, RN, James Mirocha, MS,
Lawrence S. C. Czer, MD, FACC, Robert M. Kass, MD, and Alfredo Trento, MD, FACS,
Los Angeles, Calif
We reviewed 120 consecutive robotic mitral valve repair procedures. There were 6 repair failures
between 0 and 41 days postoperatively, 5 requiring valve replacement and 1 requiring rerepair. All
patients were asymptomatic with none to mild mitral regurgitation in 89% at follow-up. Robotic
mitral valve repair is effective and reproducible.(continued on page 18A)
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TX634 Apical myectomy: A new surgical technique for management of severely
symptomatic patients with apical hypertrophic cardiomyopathy
Hartzell V. Schaff, MD, Morgan L. Brown, MD, Joseph A. Dearani, MD, Martin D. Abel, MD,
Steve R. Ommen, MD, Paul Sorajja, MD, A. Jamil Tajik, MD, and Rick A. Nishimura, MD,
Rochester, Minn, and Scottsdale, Ariz
Forty-four patients with limiting symptoms and apical hypertrophic cardiomyopathy underwent
transventricular apical myectomy. The majority had improvement in symptoms, with postoperative
studies showing increased left ventricular end-diastolic volume. Apical myectomy appears useful for
those symptomatic patients with apical hypertrophic cardiomyopathy who would otherwise be
referred for transplantation.
641 Is conventional aortic arch surgery justifiable in octogenarians?
Kenji Minatoya, MD, Hitoshi Ogino, MD, Hitoshi Matsuda, MD, Hiroaki Sasaki, MD,
Hiroshi Tanaka, MD, Junjiro Kobayashi, MD, Toshikatsu Yagihara, MD, and
Soichiro Kitamura, MD, Osaka, Japan
Results of aortic arch operations in 114 octogenarians are presented. The total hospital mortality was
7.9%. The operations were performed with an acceptable risk even under emergency situations,
including acute aortic dissection. The surgical option for aortic arch diseases should not be abandoned
only because of the high chronologic age of the patient.
646 Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac
surgery with preexisting left ventricular dysfunction: Influence on early
postoperative hemodynamics
John M. Toole, MD, John S. Ikonomidis, MD, PhD, Wilson Y. Szeto, MD, James L. Zellner, MD,
John Mulcahy, BA, Rachael L. Deardorff, BS, and Francis G. Spinale, MD, PhD, Charleston, SC,
Philadelphia, Pa, and Chattanooga, Tenn
Increased ET-AR activation occurs in patients with preexisting LV dysfunction and after cardiac
surgery requiring CPB. This initial clinical study demonstrated that infusion of a selective ET-ARA in
high-risk patients undergoing cardiac surgery was not associated with hemodynamic compromise.
ET-ARA favorably affected pulmonary vascular resistance properties in the early period after CPB.
Thus, ET-AR serves as a potential pharmacologic target for improving outcomes after cardiac surgery
in patients with compromised LV function.
655 A novel approach to prevent spinal cord ischemia: Inoue stent graft with a side
branch of small caliber for the reconstruction of the artery of Adamkiewicz
Takeshi Shimamoto, MD, Akira Marui, MD, PhD, Yoshimasa Nagata, ME, Mitsuru Sato, ME,
Naritatsu Saito, MD, PhD, Takahide Takeda, MD, Makiko Ueda, MD, PhD,
Tadashi Ikeda, MD, PhD, Ryuzo Sakata, MD, PhD, and Kanji Inoue, MD, Kyoto and Osaka, Japan
The Inoue stent graft with a side branch of 3 mm in diameter was successfully implanted onto the
thoracic aorta and 11th intercostal artery of 5 mongrel dogs. The side branch remained patent for 12
weeks. This novel technique may enable endovascular reconstruction of the Adamkiewicz artery.
660 Aortic valve reconstruction in myxomatous degeneration of aortic valves: Are
fenestrations a risk factor for repair failure?
Hans-Joachim Scha¨fers, MD, Frank Langer, MD, Petra Glombitza, MD, Takashi Kunihara, MD,
Roland Fries, MD, and Diana Aicher, MD, Homburg/Saar and Bad Scho¨nborn, Germany
Myxomatous degeneration of cusps is a cause of aortic regurgitation in tricuspid aortic valves and
might be associated with cusp fenestrations. Plication of the free margin or closure of fenestrations
leads to good functional repair in this setting.(continued on page 20A)
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TX665 Homograft aortic root replacement in native or prosthetic active infective
endocarditis: Twenty-year single-center experience
Michele Musci, MD, Yuguo Weng, MD, PhD, Michael Hu¨bler, MD, Aref Amiri, MD,
Miralem Pasic, MD, PhD, Susanne Kosky, Julia Stein, MSc, Henryk Siniawski, MD, PhD, and
Roland Hetzer, MD, PhD, Berlin, Germany
We compare the early and long-term results of cryopreserved homograft aortic root replacement
(ARR) in native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE) with periannular
abscess formation over a period of 20 years. Homograft ARR shows satisfactory early and long-term
results, with significantly better survival in NVE than in PVE. It is associated with a low endocarditis
recurrence rate, although the risk of structural valve deterioration increases over time, especially in
young patients. In our institution, the homograft remains the valve substitute of choice in this
condition.
674 Skeletonized internal thoracic artery harvesting reduces chest wall dysesthesia
after coronary bypass surgery
Phuong L. Markman, MBBS, BMedSci (Hons), Michael A. Rowland, FRACS,
Jee-Yoong Leong, MBBS, Juliana Van Der Merwe, BCur, MPhil, Elsdon Storey, DPhil, FRACP,
Silvana Marasco, MS, FRACS, Justin Negri, FRACS, Michael Bailey, PhD, MSc (Stats), and
Franklin L. Rosenfeldt, MD, FRACS, Melbourne, Australia
Harvesting of the ITA for CABG surgery is associated with postoperative dysesthesia and
neuropathic pain on the anterior chest wall, thought to be due to intercostal nerve injury. It may be
possible to reduce this complication by using skeletonized rather than pedicled harvesting of
the ITA.Perioperative
Management (PM)680 Reduction in incidence of deep sternal wound infections: Random or real?
Evan Matros, MD, Sary F. Aranki, MD, Lauren R. Bayer, PA-C, Siobhan McGurk, BS,
Jennifer Neuwalder, MD, and Dennis P. Orgill, MD, PhD, Boston, Mass
Rates of comorbidities predisposing cardiac surgical patients toward deep sternal wound infection are
increasing both nationally and locally. Despite this fact, the number of deep sternal wound infections
at our institution has significantly declined during the past 15 years. Reasons for these findings are
discussed.
686 The use of spirometry testing prior to cardiac surgery may impact the Society of
Thoracic Surgeons risk prediction score: A prospective study in a cohort
of patients at high risk for chronic lung disease
Niv Ad, MD, Linda Henry, PhD, RN, Linda Halpin, RN, MSN, Sharon Hunt, MBA,
Scott Barnett, PhD, Pamela Crippen, RN, ANP, Susan de Bullet, FNP, BC, and James Lamberti, MD,
Falls Church, Va
The underuse of spirometry suggests misclassification of chronic lung disease (CLD) in patients
undergoing cardiac surgery. In a prospective study we found that a discordant rate of 39.1% was
noted when clinical and spirometry-based evaluations were compared, with the majority (94%)
having an underestimation in severity. The use of spirometry to better classify CLD should be
considered in patients undergoing cardiac surgery.(continued on page 22A)
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TX692 Urinary proteomics before and after extracorporeal circulation in patients with
and without acute kidney injury
Fabienne Aregger, MD, Christiane Pilop, PhD, Dominik E. Uehlinger, MD, Rene´ Brunisholz, PhD,
Thierry P. Carrel, MD, Felix J. Frey, MD, and Brigitte M. Frey, PhD, Bern and Zurich, Switzerland
CPB leads to increased urinary excretion of inflammation-associated proteins or candidates of
megalin-mediated endocytosis. Zinc-alpha-1-glycoprotein is a potentially useful predictive marker
for AKI after CPB.
701 A multicenter randomized controlled trial to assess the feasibility of testing
modified ultrafiltration as a blood conservation technology in cardiac surgery
Munir Boodhwani, MD, MMSc, FRCSC, Andrew Hamilton, MD, FRCSC, Benoit de Varennes, MD,
FRCSC, Thierry Mesana, MD, PhD, FRCSC, K. Williams, George A. Wells, PhD, H. Nathan, MD,
FRCPC, Jean Yves Dupuis, MD, FRCPC, A. Babaev, MD, P. Wells, MD, MSc, FRCPC, and
Fraser D. Rubens, MD, MSc, FRCSC, Kingston and Ottawa, Ontario, and Montreal, Quebec, Canada
This study reports the results of a multicenter trial in which patients of small body size undergoing
cardiac surgery were randomized to undergo MUF to mechanically remove fluid or a control/sham
intervention. MUF successfully resulted in hemoconcentration, and anesthesiologists and intensivists
could be successfully blinded to the intervention.Evolving Technology/
Basic Science (ET/BS)707 The successful application of simulation-based training in thoracic surgery
residency
Harold M. Burkhart, MD, Jeffrey. B. Riley, CCP, Sarah E. Hendrickson, MA,
George F. Glenn, CCP, James J. Lynch, MD, Jackie J. Arnold, RN, Joseph A. Dearani, MD,
Hartzell V. Schaff, MD, and Thoralf M. Sundt III, MD, Rochester, Minn
We developed and tested a clinical simulation program in the principles and conduct of
cardiopulmonary bypass. All participants demonstrated improved confidence and proficiency in this
critical aspect of cardiac surgical care. Simulation-based cardiopulmonary bypass training appears to
be an effective technique to build the confidence of thoracic surgery residents regarding knowledge
and applications.
713 Radiofrequency ablation for Barrett’s esophagus and low-grade dysplasia in
combination with an antireflux procedure: A new paradigm
Ricardo S. dos Santos, MD, Costas Bizekis, MD, Michael Ebright, MD, Michael DeSimone,
Benedict D. Daly, MD, and Hiran C. Fernando, MD, Sa˜o Paulo, Brazil, and New York, NY
We report our initial experience with radiofrequency ablation (RFA) associated with an antireflux
procedure (ARP) for Barrett’s metaplasia (BM) and low-grade dysplasia. RFA and ARP are effective
for reducing or eliminating metaplasia and dysplasia. Long-term studies will determine whether this
approach can provide durable control of both reflux and BM.
717 Use of carotid–subclavian arterial bypass and thoracic endovascular aortic
repair to minimize cerebral ischemia in total aortic arch reconstruction
Steve Xydas, MD, Benjamin Wei, MD, Hiroo Takayama, MD, Mark Russo, MD, Matthew Bacchetta, MD,
Craig R. Smith, MD, and Allan Stewart, MD, Morristown, NJ, and New York, NY
We introduced carotid–subclavian bypass as part of aortic arch replacement with thoracic stent
grafting under short periods of selective antegrade cerebral perfusion. This approach decreased
selective antegrade cerebral perfusion time and eliminated hypothermic circulatory arrest. It may
minimize neurologic complications and provide a viable hybrid approach to arch aneurysms.(continued on page 23A)
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S723 In vivo monitoring of function of autologous engineered pulmonary valve
Danielle Gottlieb, MS, MD, MPH, Tandon Kunal, BS, Sitaram Emani, MD, Elena Aikawa, MD, PhD,
David W. Brown, MD, Andrew J. Powell, MD, Arthur Nedder, DVM, George C. Engelmayr, Jr, PhD,
Juan M. Melero-Martin, PhD, Michael S. Sacks, PhD, and John E. Mayer, Jr, MD, Boston, Mass, and
Pittsburgh, Pa
Tissue-engineered valved conduits were successfully constructed and implanted in the pulmonary
position in sheep. They functioned well initially, but pulmonary valve insufficiency developed in
follow-up.
732 The novel synthetic serine protease inhibitor CU-2010 dose-dependently
reduces postoperative blood loss and improves postischemic recovery after
cardiac surgery in a canine model
Ga´bor Szabo´, MD, PhD, Ga´bor Veres, MD, Tama´s Radovits, MD, Humaira Haider, Nelli Krieger,
Susanne Ba¨hrle, MD, Silke Niklisch, Christiane Miesel-Gro¨schel, Andreas van de Locht, PhD, and
Matthias Karck, MD, Heidelberg and Mu¨nchen, Germany; and Budapest, Hungary
The present study describes the effects of CU-2010, a novel synthetic small molecule serine protease
inhibitor, on blood loss andmyocardial and coronary vascular function in a canine model of CPBwith
cardioplegic arrest. CU-2010 dose-dependently reduced blood loss and in higher doses improved
postischemic recovery of myocardial and coronary endothelial function.
741 A multicenter prospective randomized trial of a second-generation anastomotic
device in coronary artery bypass surgery
Lars Wiklund, MD, Marek Setina, MD, Katherine Tsang, MS, Robert Cusimano, MD, MSc, and
Terrence Yau, MD, MSc, Go¨teborg, Sweden, Ceske Budejovice, Czech Republic, and Toronto,
Ontario, Canada
To evaluate a second generation anastomotic connector for vein grafts, we randomized 327 grafts
within 151 patients to the connector versus sutured proximal anastomoses. One-year patency of the
connector grafts was 92.2% and that of the sutured grafts was 91.7%.
748 Percutaneous pulmonary polyurethane valved stent implantation
Anja Metzner, PhD, Kenji Iino, MD, Ulrich Steinseifer, PhD, Anselm Uebing, MD,
Wiebke de Buhr, VMD, Jochen Cremer, MD, PhD, and Georg Lutter, MD, PhD,
Kiel and Aachen, Germany
In this study, we confirmed successful percutaneous valved stent implantation with polyurethane.ET
/BCardiothoracic
Transplantation (TX)TX
753 A 20-year experience with urgent percutaneous cardiopulmonary bypass for
salvage of potential survivors of refractory cardiovascular collapse
Brian E. Jaski, MD, Bryan Ortiz, Koteswara R. Alla, Sidney C. Smith, Jr, MD, Dale Glaser, PhD,
Cynthia Walsh, MSN, Suzanne Chillcott, BSN, RN, Marcia Stahovich, RN, CCRN,
Robert Adamson, MD, and Walter Dembitsky, MD, San Diego, Calif, and Chapel Hill, NC
In-hospital cardiac arrest or refractory shock carries a high mortality despite the use of advanced
resuscitative measures. We implemented and assessed in a 150-patient prospective registry the use of
an in-hospital, nurse-based, continuously available, percutaneous, venoarterial cardiopulmonary
bypass system as an adjunct to resuscitation when initial measures were ineffective.(continued on page 24A)
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TX758 Prevention of lung ischemia–reperfusion injury by short hairpin RNA–
mediated caspase-3 gene silencing
Yong-Xing Zhang, MD, Hong Fan, PhD, Yu Shi, MD, Song-Tao Xu, PhD, Yun-Feng Yuan, MM,
Ru-Heng Zheng, MD, and Qun Wang, PhD, Shanghai, China
In this study, we knocked down the expression of caspase-3 by intratracheal administration of short
hairpin RNA 48 hours before ischemia and prevented lung apoptotic injury in a rat model of lung
ischemia-reperfusion injury.We have shown the therapeutic potential of caspase-3 short hairpin RNA
for treating lung ischemia-reperfusion injury after transplantation.
765 Should lung transplantation be performed for patients on mechanical
respiratory support? The US experience
David P. Mason, MD, Lucy Thuita, MS, Edward R. Nowicki, MD, MS, Sudish C. Murthy, MD, PhD,
Go¨sta B. Pettersson, MD, PhD, and Eugene H. Blackstone, MD, Cleveland, Ohio
Survival after lung transplantation is worse for patients requiring preoperative intubation or
extracorporeal membrane oxygenation compared with patients not requiring mechanical support.
Reduced survival for this high-risk population raises an important issue: balancing maximal
individual patient survival against benefit to the maximum number of patients.Brief Technique Reports 774 Video-assisted intercostal nerve cryoablation in managing intractable chest
wall pain
Ian Hunt, FRCS, Donna Eaton, FRCS, Omar Maiwand, FRCS, and Vladimir Anikin, FRCS,
Harefield, Middlesex, United Kingdom
775 The Sorin Freedom SOLO stentless aortic valve: Technique of implantation and
operative results in 109 patients
Thierry Aymard, MD, Friedrich Eckstein, MD, Lars Englberger, MD, Mario Stalder, MD, Alexander
Kadner, MD, and Thierry Carrel, MD, Berne, Switzerland
777 Intraoperative recognition of an intracavitary left anterior descending coronary
artery
Lucas H. A. Sanders, MD, FCS(SA), FRACS, Mohamed A. Soliman Hamad, MD,
Mark A. J. Newman, FRACS, MD, and Bart H. van Straten, MD, Eindhoven, The Netherlands, and
Perth, Australia
778 Management of aortobronchial fistula developing 27 years after open aortic
surgery by means of endovascular stent grafting
Stefan Hacker, MD, Herbert Langenberger, MD, Christina Plank, MD, Michael Gorlitzer, MD,
Marek Ehrlich, MD, Werner Dolak, MD, So¨ren Kreuzer, MD, Christian Loewe, MD,
Walter Klepetko, MD, and Hendrik Jan Ankersmit, MD, Vienna, Austria
781 Bronchoscopic spray cryotherapy: Assessment of safety and depth of airway
injury
William S. Krimsky, MD, Jennifer N. Broussard, MD, Saiyad A. Sarkar, MD, and
Daniel P. Harley, MD, Baltimore, Md
783 Ventricular assist device implantation in neonates: Adjustment of the
BerlinHeart EXCOR arterial cannula with bovine pericardium
Tonny D. T. Tjan, MD, Andreas Hoffmeier, MD, Hans Heinrich Scheld, MD, and Stefan Klotz, MD,
Mu¨nster, Germany(continued on page 26A)
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TX785 Facilitated aortic root substitution after aortic valve replacement: Technique
and results of the prosthesis-sparing operation
Nicola Luciani, MD, Amedeo Anselmi, MD, Raphael de Geest, MD, Franco Glieca, MD, and
Gianfederico Possati, MD, Rome, Italy, and Aalst, BelgiumBrief Research Reports 788 Treatment of irradiated poststernotomy sternal nonunion with autologous stem
cell–impregnated bone matrix and sternal plating
Tomasz A. Timek, MD, Stuart B. Goodman, MD, PhD, and Richard I. Whyte, MD, MBA, Grand
Rapids, Mich, and Stanford, Calif
790 Treatment of heparin-induced thrombocytopenia after cardiac surgery:
Preliminary experience with fondaparinux
Federico Pappalardo, MD, Annamara Scandroglio, MD, Giulia Maj, MD, Alberto Zangrillo, MD,
and Armando D’Angelo, MD, Milan, ItalyOnline Only:
Brief Clinical Reportse27 Giant tracheocele
Abdul Razak, MS, Prashant H. Patil, MS, Jaspal Singh Sahota, MS, and S. Subramanian, MS,
Melaka, Malaysia
e28 Late embolization to the aortic arch of an Amplatzer Device used to occlude
a baffle leak
Prem Venugopal, MCh, FRCS, Hazem Fallouh, FRCS, and David Anderson, FRCS, London,
United Kingdom
e30 Successful implantation of a Berlin Heart ventricular assist device in ventricular
heart failure 23 years after Senning operation
Christoph Schmitz, MD, Ralf Sodian, MD, Edward Malec, MD, Katarzyna Januszewska, MD,
Ingo Kaczmarek, MD, Sieglinde Kofler, MD, Christina Bruegger, MD, Christian Kowalski, MD,
Nora Lang, MD, and Bruno Reichart, MD, Munich, Germany
e31 Ventricular septal defect repair in an infant with severe pulmonary
hypertension and preoperatively diagnosed left ventricular noncompaction
Yuki Sasaki, MD, Tsukasa Ozawa, MD, PhD, Hiroyuki Matsuura, MD, PhD,
Tsutomu Saji, MD, PhD, FACC, Takeshiro Fujii, MD, PhD, Yoshinori Watanabe, MD, PhD,
Noritsugu Shiono, MD, PhD, Yoshinori Takanashi, MD, PhD, and Nobuya Koyama, MD, PhD,
Tokyo and Sizuoka, Japan
e34 A rare case of Klebsiella pneumoniae myocardial abscess
Mohammad Abdul-Waheed, MD, Mian Atif Yousuf, MD, Eric W. Schneeberger, MD,
Tehmina Naz, MD, FACC, Daniel C. Eckert, MD, Ginger Conway, RN, CNP, and
Tarek Helmy, MD, FACC, Cincinnati, Ohio
e35 Sex reversal and hypoplastic left heart syndrome
Michael J. Walsh, MD, Elizabeth T. Walsh, MD, Yaw Appiagyei-Dankah, MD, and
Andrew M. Atz, MD, Charleston, SC
e37 Benign gastrobronchial fistula with adenocarcinoma of the right mainstem
bronchus
Simon Turcotte, MD, MSc, Isabelle L. Cayer, MD, Jean-Luc Laporte, MD, Pasquale Ferraro, MD,
Jocelyne Martin, MD, MSc, and Andre´ Duranceau, MD, Montreal, Quebec, Canada(continued on page 28A)
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TXe39 Primary pulmonary meningioma: Ten-year follow-up findings for a multiple
case, implying a benign biological nature
Yukitoshi Satoh and Yuichi Ishikawa, Tokyo and Kanagawa, Japan
e40 Angiosarcoma in the aortic arch presented as repeat strokes
Yu-Yun Nan, MD, Yuan-Chang Liu, MD, Ming-Shian Lu, MD, Sui Hsueh, MD,
Hsien-Kun Chang, MD, and Yao-Kuang Huang, MD, Linkou, Chia-Yi, and Taipei, Taiwan
e43 Late development of a large intrahepatic fistula after ‘‘closure’’ of an atrial
septal defect
Albrecht Beitzke, MD, Andreas Gamillscheg, MD, Igor Knez, MD, Erich Sorantin, MD,
Robert Maier, MD, and Martin Koestenberger, MD, Graz, Austria
e45 Optimism derived from 7.5 years of continuous-flow circulatory support
Stephen Westaby, PhD, Adrian Banning, MD, Desley Neil, MD, Philip Poole-Wilson, F Med Sci, and
O. Howard Frazier, MD, Oxford, Birmingham, and London, United Kingdom; and Houston, Tex
e47 Successful lung transplantation in an octogenarian
Norihisa Shigemura, MD, Stacey Brann, MD, Susan Wasson, CRNP, Jay Bhama, MD,
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